Pharmaceutical company.
NDAA for FY 2023 - provisions related to biological and chemical defense and access to naloxone. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S. 3799, PREVENT Pandemics Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to public health preparedness and response. H.R.1437 (P.L. 117-229), Further Continuing Appropriations and Extensions Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as they relate to pandemic preparedness.
DEF - Defense HCR - Health Issues BUD - Budget/Appropriations
1 - SENATE 1 - SENATE 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
DONALD KENT DONALD KENT DONALD KENT